Clinical trial
Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
NCT01653119 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2012
- Completion date
- December 31, 2015
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.